Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Propranolol × Sarcoma × Clear all

Phase

Status

Recruiting 2 Withdrawn 1 Unknown 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3 Plasma cell 2 CNS 2 Breast 2 Sarcoma 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1

Conditions

Hemangiosarcoma 1

Interventions

Radiotherapy 131 Temozolomide 103 Cyclophosphamide 102 Doxorubicin 101 Filgrastim 71 Ifosfamide 63 Imatinib Mesylate 62 Etoposide 60 Bevacizumab 51 Vincristine 48 Irinotecan 41 Gemcitabine 41 Peripheral Blood Stem Cell Transplantation 37 Methotrexate 36 Radiation 33 pazopanib 30 Cisplatin 30 Carboplatin 30 Busulfan 29 fludarabine phosphate 28 Trabectedin 28 Melphalan 26 Sirolimus 24 Docetaxel 23 Sunitinib 22 Magnetic Resonance Spectroscopy 22 Carmustine 22 sargramostim 21 Surgical Procedures, Operative 21 Granulocyte Colony-Stimulating Factor 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04518124 2023-11-22

Propranolol in Angiosarcoma

The Netherlands Cancer Institute

Phase 2 Completed

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡